News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aradigm Corporation (ARDM) to Participate in FDA Workshop on Non-Cystic Fibrosis Bronchiectasis


8/30/2012 10:05:49 AM

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced that Igor Gonda, PhD., Aradigm’s President and CEO, will be a panel member at the U.S. Food and Drug Administration’s public workshop regarding the design of clinical trials of antibacterial drugs for the treatment of non-cystic fibrosis bronchiectasis at the Sheraton Silver Spring Hotel in Silver Spring, MD on Friday, September 7, 2012 from 8:00 am to 3:30 pm Eastern time.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES